摘要
目的 探讨中药单体薯蓣皂苷的次皂苷元B(DRG)体外诱导HCT-15细胞凋亡的分子作用机制。方法 采用Western blotting、体外Bcl-xL蛋白竞争结合检测实验及逆转录PCR(RT-PCR)对DRG诱导细胞凋亡的机制进行了研究。结果 在HCT-15细胞中,DRG促发了线粒体调控的凋亡途径,细胞色素c呈时效性地从线粒体中释放到胞质中,同时Bax与Bcl-2蛋白表达的相对比例上调,caspase-9、caspase-3和PARP等被剪切成具有活性的片段,但是caspase-7却未见剪切,同时还不影响P53和Bcl-xL的表达;而与死亡受体途径相关的FADD表达无明显变化,caspase-8酶原也未见剪切;另外,DRG也不抑制BH3短肽与Bcl-xL的结合;RT-PCR检测结果表明,DRG诱导HCT-15细胞凋亡相关基因Bcl-2和Bax的mRNA水平的改变,进而导致Bcl-2蛋白表达水平下降,而Bax蛋白表达水平则明显增加,说明DRG诱发的细胞凋亡中涉及到Bcl-2和Bax基因水平的变化。结论 DRG诱发HCT-15细胞凋亡的分子机制在于从基因水平影响Bax和Bcl-2靶基因的转录表达,上调Bax/Bcl-2蛋白表达水平比例,并最终通过激活经典的线粒体途径而不是死亡受体途径来发挥其HCT-15细胞凋亡诱导作用,且对P53呈非依赖型。
Abstract
OBJECTIVE To investigate the molecular mechanism of the induction of apoptosis by Chinese medicine monomer diosgenin-3-O-α-L-rhamnopyranosyl-(1→4)-β-D-glucopyranoside (DRG) in HCT-15 cell in vitro. METHODS The apoptotic mechanism induced by DRG was investigated by Western blotting, in vitro Bcl-xL competitive binding assay and reverse transcription-PCR (RT-PCR) assay. RESULTS It was proved that DRG triggered a mitochondria-controlled apoptotic pathway to induce apoptosis in HCT-15 cells, which involved the release of cytochrome C from mitochondria into the cytosol in a time-dependent manner, the up-regulation of the ratio of Bax/Bcl-2 expression, and the cleavage of caspase-9, caspase-3 and PARP, without effect on the expression of P53, Bcl-xL and the cleavage of caspase-7. Whereas, the changes of proteins related to death receptor pathway such as FADD and caspase-8 were not detected. In addition, DRG was not found to inhibit the BH3 peptide from combining with Bcl-xL protein. Semi-quantitative RT-PCR indicated the changes of mRNA levels of Bcl-2 and Bax genes, which might contribute to the decreased protein levels of Bcl-2 and the increased protein levels of Bax caused by DRG, revealing that both Bcl-2 and Bax gene were involved in the apoptosis induced by DRG. CONCLUSION The molecular mechanism of DRG inducing HCT-15 cells apoptosis involves in such processes as affecting the mRNA transcription level of Bax and Bcl-2 genes, up-regulating the ratio of Bax/Bcl-2 protein expression level and at last activating classical mitochondrial pathway but not death receptor pathway and P53-independent manner to induce cell apoptosis.
关键词
细胞凋亡 /
HCT-15细胞 /
福州薯蓣 /
薯蓣皂苷次皂苷元B(DRG) /
线粒体途径 /
死亡受体途径
{{custom_keyword}} /
Key words
apoptosis /
HCT-15 cell /
Dioscorea futschauensis R. Kunth /
diocgenin-3-α-L-rhamnopyranosyl-β-D-glucopyranoside (DRG) /
mitochondrial pathway /
death receptor pathway
{{custom_keyword}} /
王三龙 罗红梅 蔡兵 崔承彬 刘宏伟 吴春福.
薯蓣皂苷的次皂苷元B(DRG)体外诱导人大肠癌HCT-15细胞凋亡的机制研究[J]. 中国药学杂志, 2011, 46(15): 1167-1172
WNG Sn-long;LUO Hong-mei;CI ing;CUI Cheng-in;LIU Hong-wei;WU Chun-fu.
Mechanism Study on Induction of Apoptosis by Diosgenin-3-O-α-L-Rhamnopyranosyl-(1→4)-β-D-Glucopyranoside (DRG) in HCT-15 Cell in Vitro[J]. Chinese Pharmaceutical Journal, 2011, 46(15): 1167-1172
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WANG S L, CAI B, CUI C B, et al. Diosgenin-3-O-α-L- rhamnopyranosyl-(1→4)-β-D-glucopyranoside a new anticancer agent from plant resources, induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway [J]. J Asian Nat Pro Res(亚洲天然产物研究), 2004,6(2):115-125.
[2] WANG S L , CAI B, CUI C B, et al. Apoptosis of human chronic myeloid leukemia K562 cell induced by diosgenin-3-O-α-L- rhamnopyranosyl-(1→4)-β-D-glucopyranoside in vitro [J]. Chin J Cancer(癌症), 2003, 22(8):795-800.
[3] OREN M. Relationship of p53 to the control of apoptotic cell death[J].Semin Cancer Biol, 1994, 5(3):221-227.
[4] KERR J F, WYLLIE A H, CURRIE A R. Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics[J].Br J Cance, 1972, 26(4):239-257.
[5] KERR J F, WINTERORD C M, HARMON B V. Apoptosis. Its significance in cancer and cancer therapy [J]. Cancer, 1994, 73(8):2013-2016.
[6] HENGARTNER M O. The biochemistry of apoptosis [J]. Nature, 2000, 407(6805):770-776.
[7] DEGTEREV A, LUGOVSKOY A, CARDONE MICHAEL, et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL [J]. Nat Cell Biol, 2001, 3(2):173-182.
[8] ENYEDY I J, LING Y, NACRO K, et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening [J]. J Med Chem, 2001, 44(25):4313-4324.
[9] TZUNG S P, KIM K M, BASANEZ G, et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3 [J]. Nat Cell Biol, 2001, 3(2):183-191.
[10] SWANTON E, SAVORY P, COSULICH S. Bcl-2 Regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts [J]. Oncogene, 1999, 18(10):1781-1787.
[11] OTTER I, CONUS S, RAVN U, et al. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli [J]. J Biol Chem, 1998, 273(11):6110-6120.
[12] HAN J, SABBATINI P, PEREZ D, et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein [J]. Genes Dev, 1996, 10(4):461-477.
[13] OLTVAI Z N, MILLIMAN C L, KORSMEYER S J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death [J]. Cell, 1993, 74(4):609-619.
[14] OLTVAI Z N, KORSMEYER S J. Checkpoints of dueling dimers foil death wishes [J]. Cell, 1994, 79(2):189-192.
[15] YIN X M, OLTVAI Z N, KORSMEYER S J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [J]. Nature, 1994, 369(6478):321-323.
[16] YANG E, ZHA J P, JOCKEL J, et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death [J]. Cell, 1995, 80(2):285-291.
[17] BRUCE M C, HONAKER C E, CROSS R J. Lung fibroblasts undergo apoptosis following alveoalrization [J]. Am J Respir Cell Mol Biol, 1999, 20(2):228-236.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}